Cargando...
Discovery of new biomarkers for malignant mesothelioma
Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...
Gardado en:
| Publicado en: | Curr Pulmonol Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356891/ https://ncbi.nlm.nih.gov/pubmed/25927434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13665-015-0106-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|